The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography

1. POCHA C, KOLLY P, DUFOUR JF. Nonalcoholic fatty liver disease-related hepatocellular carcinoma: A problem of growing magnitude. Semin Liver Dis. 2015; 35(3):304-17.10.1055/s-0035-156294926378646Search in Google Scholar

2. FRIEDRICH-RUST M, SCHOELZEL F, MAIER S, SEEGER F, REY J, FICHTLSCHERER S, et al. Severity of coronary artery disease is associated with non-alcoholic fatty liver disease: A single-blinded prospective mono-center study. PLoS One. 2017; 12(10):e0186720.10.1371/journal.pone.0186720565807629073252Search in Google Scholar

3. PERERA N, INDRAKUMAR J, ABEYSINGHE WV, FERNANDO V, SAMARAWEERA WM, LAWRENCE JS. Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: An observational study from Sri Lanka. BMC Cardiovasc Disord. 2016;16:37.10.1186/s12872-016-0212-8475170126869052Search in Google Scholar

4. GAUDIO E, NOBILI V, FRANCHITTO A, ONORI P, CARPINO G. Nonalcoholic fatty liver disease and atherosclerosis. Intern Emerg Med. 2012; 7 Suppl 3:S297-305.10.1007/s11739-012-0826-523073871Search in Google Scholar

5. BONCI E, CHIESA C, VERSACCI P, ANANIA C, SILVESTRI L, PACIFICO L. Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: A systematic review and meta-analysis. Biomed Res Int. 2015; 2015:213737.10.1155/2015/213737452989926273598Search in Google Scholar

6. PARK HE, KWAK MS, KIM D, KIM MK, CHA MJ, CHOI SY. Nonalcoholic fatty liver disease is associated with coronary artery calcification development: A longitudinal study. J Clin Endocrinol Metab. 2016; 101(8):3134-43.10.1210/jc.2016-152527253666Search in Google Scholar

7. LI XL, SUI JQ, LU LL, ZHANG NN, XU X, DONG QY, et al. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: A concise review. Lipids Health Dis. 2016; 15:53.10.1186/s12944-016-0221-8478561626965314Search in Google Scholar

8. NSEIR W, SHALATA A, MARMOR A, ASSY N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Dig Dis Sci. 2011; 56(12):3439-49.10.1007/s10620-011-1767-y21655948Search in Google Scholar

9. ADAMS LA, ANSTEE QM, TILG H, TARGHER G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017; 66(6):1138-53.10.1136/gutjnl-2017-31388428314735Search in Google Scholar

10. WANG P-W, HSIEH C-J, PSANG L-C, CHENG Y-F, LIOU C-W, WENG S-W, et al. Fatty liver and chronic inflammation in Chinese adults. Diabetes Research and Clinical Practice. 2008; 81(2):202-08.10.1016/j.diabres.2008.04.01418534708Search in Google Scholar

11. PASARIN M, ABRALDES JG, LIGUORI E, KOK B, LA MURA V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol. 2017; 23(37):6777-87.10.3748/wjg.v23.i37.6777564561229085222Search in Google Scholar

12. KLISIC A, ISAKOVIC A, KOCIC G, KAVARIC N, JOVANOVIC M, ZVRKO E, et al. Relationship between oxidative stress, inflammation and dyslipidemia with fatty liver index in patients with type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2017.10.1055/s-0043-11866728895641Search in Google Scholar

13. KIM J, LEE DY, PARK SE, PARK CY, LEE WY, OH KW, et al. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation. PLoS One. 2017; 12(7):e0180118.10.1371/journal.pone.0180118550145928686633Search in Google Scholar

14. KOROGLU E, CANBAKAN B, ATAY K, HATEMI I, TUNCER M, DOBRUCALI A, et al. Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease. Turk J Gastroenterol. 2016; 27(4):361-6.10.5152/tjg.2016.1610627458852Search in Google Scholar

15. EMRE A, TERZI S, CELIKER E, SAHIN S, YAZICI S, ERDEM A, et al. Impact of nonalcoholic fatty liver disease on myocardial perfusion in nondiabetic patients undergoing primary percutaneous coronary intervention for ST - segment elevation myocardial infarction. The American Journal of Cardiology. 2015; 116(12):1810-4.10.1016/j.amjcard.2015.09.02126506122Search in Google Scholar

16. WANG Y, LI YY, NIE YQ, ZHOU YJ, CAO CY, XU L. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine. 2013; 6(1):77-84.10.3892/etm.2013.1090373556823935723Search in Google Scholar

17. NADERIAN M, KOLAHDOOZAN S, SHARIFI AS, GARMAROUDI G, YASERI M, POUSTCHI H, et al. Assessment of lean patients with non-alcoholic fatty liver disease in a middle income country; Prevalence and its association with metabolic disorders: A cross-sectional study. Archives of Iranian Medicine. 2017; 20(4):211-17.Search in Google Scholar

18. WU R, HOU F, WANG X, ZHOU Y, SUN K, WANG Y, et al. Nonalcoholic fatty liver disease and coronary artery calcification in a northern Chinese population: A cross sectional study. Sci Rep. 2017; 7(1):9933.10.1038/s41598-017-09851-5557729228855585Search in Google Scholar

19. BAHARVAND-AHMADI B, SHARIFI K, NAMDARI M. Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease. ARYA Atheroscler. 2016; 12(4):201-05.Search in Google Scholar

20. SUN L, LU SZ. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin Med J (Engl). 2011; 124(6):867-72.Search in Google Scholar

21. CHOI DH, LEE SJ, KANG CD, PARK MO, CHOI DW, KIM TS, et al. Nonalcoholic fatty liver disease is associated with coronary artery disease in Koreans. World J Gastroenterol. 2013; 19(38):6453-7.10.3748/wjg.v19.i38.6453380131624151364Search in Google Scholar

22. ARSLAN U, TURKOGLU S, BALCIOGLU S, TAVIL Y, KARAKAN T, CENGEL A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007; 18(6):433-6.10.1097/MCA.0b013e3282583c0d17700213Search in Google Scholar